KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Assets (2019 - 2025)

Moderna (MRNA) has disclosed Return on Assets for 5 consecutive years, with 0.25% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Assets changed N/A to 0.25% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.25%, a N/A change, with the full-year FY2022 number at 0.33%, down 43.0% from a year prior.
  • Return on Assets was 0.25% for Q1 2025 at Moderna, down from 0.56% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.56% in Q1 2022 to a low of 0.25% in Q1 2025.
  • A 3-year average of 0.25% and a median of 0.31% in 2021 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 66bps in 2021; the steepest drop was 34bps in 2021.
  • Moderna's Return on Assets stood at 0.54% in 2021, then rose by 5bps to 0.56% in 2022, then tumbled by -145bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Return on Assets are 0.25% (Q1 2025), 0.56% (Q1 2022), and 0.54% (Q4 2021).